Silver Lake Advisory’s Meridian Bioscience Inc VIVO Stock Holding History

Silver Lake Advisory’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-32,106	Closed	-$565K	–	84
2019 Q1	$565K	Sell	32,106 -5,018	-14%	-$83.5K	0.38%	59
2018 Q4	$644K	Buy	37,124 +215	+0.6%	+$3.67K	0.48%	55
2018 Q3	$550K	Buy	+36,909	New	+$572K	0.33%	67
2018 Q2	–	Sell	-36,376	Closed	-$517K	–	91
2018 Q1	$517K	Sell	36,376 -194	-0.5%	-$2.87K	0.38%	60
2017 Q4	$512K	Buy	+36,570	New	+$535K	0.36%	59

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silver Lake Advisory's VIVO Position: Q2 2019 in Review

Silver Lake Advisory sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 32,106 shares — an estimated $565K sold.

Silver Lake Advisory first reported a position in VIVO in Q4 2017 and held it in 5 quarters. The position peaked at $644K in Q4 2018. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Silver Lake Advisory reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Silver Lake Advisory sold 32,106 Meridian Bioscience Inc shares in Q2 2019, an estimated $565K.
Silver Lake Advisory first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 5 quarters.
Silver Lake Advisory's Meridian Bioscience Inc position peaked at $644K in Q4 2018.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Silver Lake Advisory's 13F filing for Q2 2019, filed 1 Aug 2019.